TREATING DEADLY INFLAMMATION

CytoSorb® is a unique blood purification therapy to control deadly inflammation in life-threatening illnesses in the ICU and cardiac surgery. The product is currently approved in the European Union and distributed in 58 countries around the world.

THE POWER OF THE BEAD

Powered by massive surface area, our purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption.

INFORMATION FOR INVESTORS

CytoSorbents is a leader in critical care immunotherapy.  The company is committed to serving the best interests of our patients and their families, our customers, our employees, and our shareholders.

What is CytoSorb?


What is CytoSorb

CytoSorbents CEO Dr. Phillip Chan on The Street, discussing how CytoSorbents flagship treatment CytoSorb has been used to treat 65 patients in China as well as in Italy with COVID-19 infection.click here